Tissue Replacement Articles & Analysis: Older
23 news found
High-intensity focused ultrasound is a medical technology that uses the thermal effect of ultrasound to eliminate diseased tissue in the body. The way HIFU works is similar to the principle of burning paper at the focus after sunlight is focused by a magnifying glass. ...
High-intensity focused ultrasound is a medical technology that uses the thermal effect of ultrasound to eliminate diseased tissue in the body. The way HIFU works is similar to the principle of burning paper at the focus after sunlight is focused by a magnifying glass. 2. ...
About MatTek Founded in 1985, MatTek Life Sciences began producing three-dimensional human tissue models as reliable replacements for animal testing. MatTek’s physiologically advanced tissue models empower companies in the cosmetics, chemical, and pharmaceutical industries to achieve their goals of non-animal testing while lowering ...
MatTek Life Sciences will produce and distribute EpiOral from its production facility in Slovakia, continuing the BICO groups’ focus on providing on-demand tissues to the European market. MatTek Life Sciences, a Boston-area tissue engineering company and a part of the BICO Group, announced today its European facility in Bratislava, Slovakia, will begin ...
Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore lost function. ...
No severe adverse events were observed in any participating patients. “By replacing lost neurons in the midbrain region of patients with Parkinson’s disease, we have the potential to regenerate lost function and possibly improve and reverse the disease,” states Joachim Fruebis, Ph.D., Chief Development Officer of BlueRock Therapeutics. ...
It has been estimated that over 2 million partial meniscectomies are performed annually worldwide in an attempt to alleviate pain; however, studies have shown that many people who get a meniscectomy continue to experience pain that impacts their quality of life and can eventually lead to knee replacement surgery. Transplant tissue is scarce, and in many ...
(“Nalu”), a California-based company that has successfully miniaturized neurostimulation implants for chronic intractable pain management indications, announces its Nalu micro-Implantable Pulse Generator (mIPG) was named the Implant and Tissue-Replacement device Gold Winner at the 2021 Medical Design Excellence Awards (MDEA). ...
” About IDCT IDCT is a homologous, allogeneic, injectable cell therapy that utilizes proprietary Discogenic Cells, which are biomedically engineered progenitor cells that have been derived from intervertebral disc tissue. Discogenic Cells are reproducibly manufactured in a highly controlled environment under current good manufacturing practices (cGMP) and subjected to ...
“Our therapy is intended to replace the midbrain dopaminergic neurons lost in the degenerative condition to rebuild the neural circuit, and thereby restore motor control to Parkinson’s patients. ...
Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. ...
“Our therapy is intended to replace the midbrain dopaminergic neurons lost in the degenerative condition to rebuild the neural circuit, and thereby restore motor control to Parkinson’s patients. ...
Following a long history of enthusiasm, researchers however began to question the integrity of the procedures being performed, specifically, the tissues being transplanted, and began wondering whether it was possible to create, grow, and harvest these tissues in the laboratory. Thus began the era of ‘Tissue Engineering’. Fast forward ...
Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. ...
MUNICH, Germany – February 4th, 2020: In the future, novel polymers should make it possible to individually manufacture artificial elastic tissue replacements for pericardium, heart valves or blood vessels. In the PolyKARD project, biomimetic polymers are being developed that can imitate the mechanical properties of pericardial tissue. ...
IDCT is a homologous, allogeneic, injectable cell therapy that utilizes biomedically engineered progenitor cells, known as Discogenic Cells, that have been derived from intervertebral disc tissue to offer a non-surgical, potentially regenerative solution for the treatment of mild to moderate DDD. ...
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference featuring more than 80 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader ...
Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. ...
Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. ...
Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. ...